Fact Based List:

Top U.S. Life Science R&D Expenditures for Q1-Q3 2012

Submitted by Anonymous on Thu, 12/20/2012 - 14:20


  1. Pfizer - $5,734
  2. Merck & Co. - $5,945
  3. Johnson & Johnson - $5,334
  4. Lilly (Eli) & Co. - $3,815
  5. Abbott Laboratories - $3,181
  6. Bristol-Myers Squibb Co. - $2,822
  7. Amgen - $2,411
  8. Celgene - $1,251
  9. Medtronic (estimated) - $1,167
  10. Monsanto - $1,166

Notes: In millions
Source: Battelle/R&D Magazine
Source URL: http://www.battelle.org/docs/default-document-library/2013-R...



List Ratings:   
0
No votes yet
Your rating: None

Lists You Might Also Be Interested In



Login or register to post comments